Binh Dinh Pharmaceutical & Medical Equipment JSC (DBD) Stock Analysis

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Poor long term growth as Net Sales has grown by an annual rate of 6.75% over the last 5 years

Negative results in Jun 25

With ROE of 18.73%, it has a fair valuation with a 3.07 Price to Book Value

Below par performance in long term as well as near term

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

VND 4,677,218 Million (Small Cap)

P/E

16.00

Industry P/E

Dividend Yield

3.20%

Debt Equity

-0.23

Return on Equity

17.08%

Price to Book

2.74

Revenue and Profits:

Net Sales:

474,537 Million

(Quarterly Results - Jun 2025)

Net Profit:

90,336 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-8.92%

6 Months

-9.43%

1 Year

-16.1%

2 Years

7.46%

3 Years

34.8%

4 Years

-8.07%

5 Years

9.62%

Binh Dinh Pharmaceutical & Medical Equipment JSC for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

6.75%

EBIT Growth (5y)

12.83%

EBIT to Interest (avg)

70.23

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.21

Sales to Capital Employed (avg)

1.07

Tax Ratio

15.36%

Dividend Payout Ratio

79.06%

Pledged Shares

Institutional Holding

ROCE (avg)

22.57%

ROE (avg)

17.11%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

3.07

EV to EBIT

13.70

EV to EBITDA

11.92

EV to Capital Employed

3.84

EV to Sales

2.50

PEG Ratio

Dividend Yield

2.98%

ROCE (Latest)

28.06%

ROE (Latest)

18.73%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bearish

RSI

Bullish

No Signal

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Mildly Bearish

Dow Theory

Mildly Bearish

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 7.59% vs -7.71% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 11.51% vs 33.63% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "474,537.00",
          "val2": "441,045.10",
          "chgp": "7.59%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "115,585.90",
          "val2": "100,563.60",
          "chgp": "14.94%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "785.00",
          "val2": "719.60",
          "chgp": "9.09%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "90,336.50",
          "val2": "81,009.30",
          "chgp": "11.51%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "215.90%",
          "val2": "199.90%",
          "chgp": "1.60%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 4.59% vs 6.24% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 2.28% vs 10.47% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,727,548.40",
          "val2": "1,651,769.60",
          "chgp": "4.59%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "353,704.60",
          "val2": "342,951.20",
          "chgp": "3.14%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "4,058.10",
          "val2": "6,998.40",
          "chgp": "-42.01%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "236,656.50",
          "val2": "231,387.20",
          "chgp": "2.28%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "176.90%",
          "val2": "179.80%",
          "chgp": "-0.29%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ

Jun'25

Mar'25

Change(%)

Net Sales

474,537.00

441,045.10

7.59%

Operating Profit (PBDIT) excl Other Income

115,585.90

100,563.60

14.94%

Interest

785.00

719.60

9.09%

Exceptional Items

0.00

Consolidate Net Profit

90,336.50

81,009.30

11.51%

Operating Profit Margin (Excl OI)

215.90%

199.90%

1.60%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Jun 2025 is 7.59% vs -7.71% in Mar 2025

Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is 11.51% vs 33.63% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

1,727,548.40

1,651,769.60

4.59%

Operating Profit (PBDIT) excl Other Income

353,704.60

342,951.20

3.14%

Interest

4,058.10

6,998.40

-42.01%

Exceptional Items

0.00

Consolidate Net Profit

236,656.50

231,387.20

2.28%

Operating Profit Margin (Excl OI)

176.90%

179.80%

-0.29%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 4.59% vs 6.24% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 2.28% vs 10.47% in Dec 2023

All Annual Results

Company CV

About Binh Dinh Pharmaceutical & Medical Equipment JSC

Binh Dinh Pharmaceutical & Medical Equipment JSC

Pharmaceuticals & Biotechnology

Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company (Bidiphar) is a Vietnam-based company primarily engaged in pharmaceuticals sector. The Company's leading business activities are the production and wholesale of medicines, including antibiotics, antipyretics, pain relievers, cardiovascular drugs, antifungal and antiviral drugs, respiratory drugs, vitamins and functional food, among others. Bidiphar is also involved in the manufacture and distribution of medical equipment, supplies and packaging.

Company Coordinates

Company Details

498 Nguyen Thai Hoc, Phuong Quang Trung , QUI NHON None : None

Tel: 84 25 63846500

http://www.bidiphar.com/

Registrar Details